Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 77060169 |
Registration Number | 3918394 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Cancellation Code | 2 |
Attorney Name | Andrew J. Ferren |
Attorney Docket Number | 11352.0001 |
Law Office Assigned | L50 |
Employee Name | DUBRAY, KATHERINE M |
2006-12-08 | Application Filed |
2007-07-24 | Published for Opposition |
2011-02-15 | Location: PUBLICATION AND ISSUE SECTION |
2011-02-15 | Trademark Registered |
2017-09-22 | Cancelled |
2017-09-22 | Status: Dead/Cancelled |
2018-07-08 | Transaction Date |
Owner: | ![]() |
Entity Statement | GMBH |
Address | Im Neuenheimer Feld 584 69120 Heidelberg DE |
Legal Entity Type | |
Legal Entity State | DE |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Pharmaceutical products and preparations for the treatment of pneumonitis; pharmaceutical products and preparations for the treatment of graft-versus-host disease (GVHD); pharmaceutical products and preparations for the treatment of acute cardiovascular diseases; pharmaceutical products and preparations for the treatment of cancer diseases; pharmaceutical products and preparations for the treatment of skin disorders; pharmaceutical products and preparations for the treatment of wound healing; pharmaceutical products and preparations for the treatment of transplant rejection/graft rejection; pharmaceutical products and preparations for use in the treatment of diseases by modulating effects such as cell proliferation, cell differentiation, cell migration, and cell death; all of the foregoing goods excluding pharmaceutical products and preparations for the treatment of cerebral and neurological disorders, diseases and conditions |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2006-12-13 | 1 NWAP I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2007-04-02 | 2 DOCK D:Assigned to Examiner |
PRIORITY ACTION WRITTEN | 2007-04-03 | 3 CPRA R:Renewal |
PRIORITY ACTION E-MAILED | 2007-04-03 | 4 GPRA F:First Action |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2007-05-24 | 5 TROA I:Incoming Correspondence |
ASSIGNED TO LIE | 2007-06-11 | 6 ALIE A:Allowance for Publication |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2007-06-11 | 7 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2007-06-11 | 8 TEME I:Incoming Correspondence |
EXAMINERS AMENDMENT -WRITTEN | 2007-06-14 | 9 CNEA R:Renewal |
EXAMINERS AMENDMENT E-MAILED | 2007-06-14 | 10 GNEA O:Outgoing Correspondence |
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2007-06-14 | 11 GNEN O:Outgoing Correspondence |
EXAMINER'S AMENDMENT ENTERED | 2007-06-14 | 12 XAEC I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2007-06-15 | 13 CNSA O:Outgoing Correspondence |
LAW OFFICE PUBLICATION REVIEW COMPLETED | 2007-06-15 | 14 PREV O:Outgoing Correspondence |
NOTICE OF PUBLICATION | 2007-07-04 | 15 NPUB O:Outgoing Correspondence |
PUBLISHED FOR OPPOSITION | 2007-07-24 | 16 PUBO A:Allowance for Publication |
EXTENSION OF TIME TO OPPOSE RECEIVED | 2007-08-14 | 17 ETOF T:TTAB Proceeding |
OPPOSITION INSTITUTED NO. 999999 | 2007-11-20 | 18 OP.I T:TTAB Proceeding |
ASSIGNED TO EXAMINER | 2009-11-27 | 19 DOCK D:Assigned to Examiner |
PAPER RECEIVED | 2010-12-06 | 20 MAIL I:Incoming Correspondence |
OPPOSITION DISMISSED NO. 999999 | 2011-01-07 | 21 OP.D T:TTAB Proceeding |
OPPOSITION TERMINATED NO. 999999 | 2011-01-07 | 22 OP.T T:TTAB Proceeding |
TTAB RELEASE CASE TO TRADEMARKS | 2011-01-07 | 23 TMBN T:TTAB Proceeding |
REGISTERED-PRINCIPAL REGISTER | 2011-02-15 | 24 R.PR A:Allowance for Publication |
CANCELLED SEC. 8 (6-YR) | 2017-09-22 | 25 C8.. O:Outgoing Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.